Long-term comparison of everolimus- vs. novolimus-eluting bioresorbable vascular scaffolds in real world patients
The largest amount of evidence for bioresorbable vascular scaffold (BVS) use in clinical practice derives from Absorb trials and registries. Comparison of Absorb BVS with metallic stents resulted in increased rates of target lesion failure and device thrombosis in the Absorb BVS group. We investigat...
Guardado en:
Autores principales: | Beytullah Cakal, Sinem Cakal, Oguz Karaca, Mehmet Omaygenc, Filiz Yilmaz, Haci Gunes, Ozgur Ozcan, Arzu Yıldırım, Bilal Boztosun |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e3cd304ec9144aedbc315e1eb6589b5f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
por: Piotr Desperak, et al.
Publicado: (2020) -
Bioresorbable vascular scaffolds technology: current use and future developments
por: Giacchi G, et al.
Publicado: (2016) -
Long-term (> 12 months) single-center registry of Magmaris implantation in the acute coronary syndrome setting
por: Jeremías Bayón, et al.
Publicado: (2021) -
Long-term outcomes of Absorb bioresorbable vascular scaffold using predilation, sizing, and postdilation protocol in a real-world patient population
por: Sinem Çakal, et al.
Publicado: (2021) -
Failed transcatheter mitral valve-in-ring implantation followed by transapical valve-in-valve within the ring and ad hoc paravalvular leak closure
por: Beytullah Çakal, et al.
Publicado: (2021)